Cerebral Protection in Transcatheter Aortic Valve Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 363 participants.

Also called NCT02214277

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 363 participants (enrolled count) (from the registry)
Sponsor
Claret Medical (from the registry)
Registry
  • NCT NCT02214277
Other papers using this trial's data
  • Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement Journal of the American College of Cardiology, 2017-01-31 DOI, PubMed 27815101

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02214277. Randomized; double masking; primary purpose prevention. Start 2014-09 (registry gives no type); primary completion 2016-03 (actual). Results posted on 2018-05-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cerebral Protection in Transcatheter Aortic Valve Replacement
Condition
Severe Symptomatic Calcified Native Aortic Valve Stenosis
Intervention (Device)
Cerebral Protection System-The SENTINEL System with TAVR (transcatheter aortic valve replacement)
Intervention (Device)
TAVR
Lead sponsor
Claret Medical (class: industry)

Record details

Record id
cardio:ct-nct02214277
Content hash
7d142c1b63a51d581a415fab5098456ab7703518ae1797786bdb301c732d111d